Pharma: Other News To Note
Thursday, August 16, 2012
Renaissance Pharma Inc., of Newtown, Pa., acquired the U.S. rights to manufacture, market and sell Denavir (1 percent penciclovir cream) from investment funds managed by Deerfield Management Co. and New American Therapeutics Inc., of Cranford, N.J.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.